Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Finnish researchers link morning sickness during regency to depression
MENAFN
(MENAFN) Researchers at the University of Turku in Finland have found that severe morning sickness during pregnancy is associated with an increased risk of depression.
Living with a Rare Disease: A Pastor’s Journey Finding the Right Care and Treatment for NF1-PN
GlobeNewswire, Inc.
STAMFORD, Conn., March 02, 2026 (GLOBE NEWSWIRE) -- Did you know neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN) is a rare genetic disorder that can cause tumors to grow along nerves, leading to pain, mobility challenges, and...
This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease
GlobeNewswire, Inc.
DUBLIN and BRIDGEWATER, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today issued a call to action for American Heart Month...
A Guide to Philadelphia’s Top Luxury Wellness & Recovery Spots
Visit Philly - Pennsylvania
PHILADELPHIA, February 27, 2026 – In 2026, spa getaways are evolving into intentional mini staycations, answering guests’ longing for deeper connection and intentional rest.
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
GlobeNewswire, Inc.
Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson’s disease, following completion of study preparations Espoo, Finland, 19 February 2026: Herantis Pharma Plc (“Herantis”), a clinical-stage biotech company...
Finland Sees Resurgence in COVID Cases as 200 Reported Weekly
MENAFN
(MENAFN) Finland is witnessing a resurgence in COVID-19 infections, with health authorities documenting 200 laboratory-confirmed cases weekly amid a broader wave of respiratory illnesses sweeping the nation, a broadcaster reported Monday.
California and France build on a decade of cooperation with new partnership to strengthen clean energy, protect communities, and grow economic opportunity
Office of the California Governor
Turning shared challenges into practical solutions The partnership establishes a framework for cooperation across climate action and environmental protection.
California and France build on a decade of cooperation with new partnership to strengthen clean energy, protect communities, and grow economic opportunity
Office of the California Governor
Turning shared challenges into practical solutions The partnership establishes a framework for cooperation across climate action and environmental protection.
What is the Open Dialogue approach in mental health?
Rethink Mental Illness
Open Dialogue is a collaborative way of supporting someone through a mental health crisis, focusing on the whole family and support network instead of just the individual.
Nordic healthcare gets a voice: Speechmatics cuts medical transcription errors by 40% with new Swedish model
GlobeNewswire, Inc.
CAMBRIDGE, United Kingdom, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Speechmatics today launched a medical-grade Swedish speech-to-text model achieving 3.91% keyword error rate (KWER) on medical terms—40% lower than the closest competitor—expanding the...
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire, Inc.
CAMPBELL, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs,...
Verdane Invests in Clue to Accelerate the Future of Women’s Health
GlobeNewswire, Inc.
BERLIN, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Clue, the #1 women-led period and cycle tracker health and wellness app, with over 100 million downloads worldwide, today announced a significant and strategic investment from Verdane - the European...
High Levels of Trust Elevate the Fortune 100 Best Companies to Work For, Europe in 2026
GlobeNewswire, Inc.
Oakland, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Great Place To Work® and Fortune Europe announce the 2026 Fortune 100 Best Companies to Work For™ Europe, highlighting the best employers, regardless of industry or country of origin.
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
GlobeNewswire, Inc.
Herantis Pharma Plc – Company release Inside information: Herantis Pharma – Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease Biomarker data show that HER-096 modulates Parkinson’s...
Europe Contract Catering Market Set for USD 70.73 Bn Growth as Demand Shifts Across Corporate, Healthcare, and Education
EIN Presswire
Europe’s Contract Catering Market Shifts Toward Scale-Driven, High-Density Service Environments CHICAGO, IL, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- Europe’s contract catering market is entering a phase where growth is being...
Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 8 JANUARY 2026 at 12.00 EET Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE) Orion Corporation (Orion...
Boston Announces $700,000 in Overdose Response Grants for Community Organizations
City of Boston
Boston Public Health Commission is also announcing expansion of care coordination and street outreach initiatives.
Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096
GlobeNewswire, Inc.
Key step achieved in advancing HER-096 towards Phase 2 efficacy trial Espoo, Finland, 26 November 2025: Herantis Pharma Plc (“Herantis”), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s...
ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States
EIN Presswire
Expanded collaboration significantly broadens ACA Pharma’s ex-U.S. commercialization footprint for RYANODEX® NEW YORK, NY, UNITED STATES, November 24, 2025 /EINPresswire.com/ -- ACA Pharma today announced a significant expansion of their...
Adalyon Appoints Ulrik Zeuthen as CEO to Drive Next Phase of Growth in AI-driven Speech-based Biomarkers and Behavioural Analytics for Optimising Clinical Trials
GlobeNewswire, Inc.
ESPOO, Finland, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Adalyon, a pioneering tech-bio company using its AI-powered speech biomarker platform to transform clinical drug development, today announced the appointment of Ulrik Zeuthen, as Chief Executive...
Sign up for:
Health Daily Finland
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.